Welcome to LookChem.com Sign In|Join Free

CAS

  • or

676-26-6

Post Buying Request

676-26-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

676-26-6 Usage

Also known as

14-bromomyristic acid

Type of compound

Fatty acid

Specific type

Brominated derivative of tetradecanoic acid

Physical state at room temperature

White to off-white solid

Solubility

Insoluble in water, soluble in organic solvents

Uses

1. Synthesis of organic compounds and pharmaceuticals
2. Production of surfactants and emulsifiers for cosmetics, personal care products, and pharmaceuticals
3. Potential applications in agriculture as a pesticide
4. Production of plastics and rubber products

Hazardous properties

Can cause skin and eye irritation, harmful if ingested or inhaled

Check Digit Verification of cas no

The CAS Registry Mumber 676-26-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,7 and 6 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 676-26:
(5*6)+(4*7)+(3*6)+(2*2)+(1*6)=86
86 % 10 = 6
So 676-26-6 is a valid CAS Registry Number.

676-26-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 14-bromotetradecanoic acid

1.2 Other means of identification

Product number -
Other names 14-bromo-tetradecanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:676-26-6 SDS

676-26-6Relevant articles and documents

INSULIN CONJUGATES

-

Paragraph 0580-0583; 0584, (2020/07/05)

The present invention relates to a conjugate comprising a sulfonamide of formula (I) and an active pharmaceutical ingredient such as an insulin analog comprising at least one mutation relative to the parent insulin, wherein the insulin analog comprises a mutation at position B16 which is substituted with a hydrophobic amino acid and/or a mutation at position B25 which is substituted with a hydrophobic amino acid. The present invention further relates to a sulfonamide of formula (A). Moreover, the present invention relates to an insulin analog comprising at least one mutation relative to the parent insulin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 676-26-6